ArborGen (RUBNF) Stock Price, News & Analysis

Company Overview

ArborGen is a leading developer and supplier of advanced genetic and biotechnological products for the forestry industry. The company focuses on the improvement of tree performance through selective breeding, genetic engineering, and tissue culture propagation. ArborGen’s portfolio includes improved seedlings and cuttings for loblolly and slash pine, eucalyptus, poplar, and other commercially important species, designed to enhance growth rates, disease resistance, and wood quality.

The company operates state-of-the-art laboratories and nurseries in the United States, Chile, New Zealand, South Africa, and Australia. These facilities enable ArborGen to conduct field trials, maintain elite breeding populations, and deliver containerized and bareroot seedlings tailored to regional planting conditions. The integration of genomics, phenotyping, and conventional breeding techniques allows ArborGen to accelerate the development of high-value planting stock and support sustainable forestry practices.

ArborGen’s products serve a broad range of customers, including industrial forestry companies, independent timberland owners, and government agencies. In addition to traditional plantation forestry, the company’s offerings support biomass and bioenergy initiatives, pulp and paper production, and reforestation projects aimed at environmental restoration and carbon sequestration. ArborGen works closely with forestry professionals to ensure planting material meets specific yield, soil, and climatic requirements.

Founded in the early 2000s through the consolidation of several forest biotechnology businesses, ArborGen has grown into a global provider of advanced forest regeneration products. The company is headquartered in Summerville, South Carolina, and is led by a management team with deep expertise in forestry genetics, commercial nurseries, and biotechnology. ArborGen’s leadership continues to drive innovation in tree improvement and to expand market access for its proprietary seedling and tissue-culture solutions.

Key Stats

• Today's Range: $0.07 to $0.07
• 50-Day Range: $0.04 to $0.07
• 52-Week Range: $0.04 to $0.08
• Volume: N/A
• Average Volume: 26,300 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

RUBNF Stock Analysis - Frequently Asked Questions

How have RUBNF shares performed this year?

ArborGen's stock was trading at $0.06 at the start of the year. Since then, RUBNF stock has increased by 16.7% and is now trading at $0.07.

How do I buy shares of ArborGen?

Shares of RUBNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Lumber & Wood Production
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:RUBNF
• CIK: N/A
• Web: www.rubicon-nz.com
• Phone: (649) 356-9800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A